Resumen de acción BCPC
Balchem Corporation desarrolla, fabrica y comercializa ingredientes y productos especiales de alto rendimiento para los mercados nutricional, alimentario, farmacéutico, de salud animal, de esterilización de dispositivos médicos, de nutrición vegetal e industrial de todo el mundo.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de Balchem Corporation
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$141.38 |
| 52 Week High | US$159.52 |
| 52 Week Low | US$110.74 |
| Beta | 0.70 |
| 1 Month Change | -8.76% |
| 3 Month Change | 0.87% |
| 1 Year Change | 8.33% |
| 3 Year Change | 5.82% |
| 5 Year Change | 42.46% |
| Change since IPO | 56,405.44% |
Noticias y actualizaciones recientes
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21
Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Recent updates
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?
Aug 22Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?
Aug 08Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement
May 30Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
May 18Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
May 02Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Mar 28Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Feb 26Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Dec 23Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Nov 18We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Sep 22Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Aug 16Balchem: Good Quarterly Performance Priced In
Aug 02These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 12Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
May 13Balchem EPS beats by $0.03, beats on revenue
Apr 30Balchem: All Eyes On M&A And Autism Drug
Apr 26Is Balchem (NASDAQ:BCPC) A Risky Investment?
Mar 14How Many Balchem Corporation (NASDAQ:BCPC) Shares Have Insiders Sold, In The Last Year?
Feb 27Rentabilidad de los accionistas
| BCPC | US Chemicals | Mercado US | |
|---|---|---|---|
| 7D | -2.5% | -0.3% | -0.7% |
| 1Y | 8.3% | 6.7% | 22.3% |
Rentabilidad vs. Industria: BCPC igualó al sector US Chemicals , que obtuvo un rendimiento del 6.3% el año pasado.
Rentabilidad vs. Mercado: BCPC obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| BCPC volatility | |
|---|---|
| BCPC Average Weekly Movement | 3.2% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: BCPC no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de BCPC (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1967 | 1,302 | Ted Harris | www.balchem.com |
Balchem Corporation desarrolla, fabrica y comercializa ingredientes y productos especiales de alto rendimiento para los mercados nutricional, alimentario, farmacéutico, de salud animal, de esterilización de dispositivos médicos, de nutrición vegetal e industrial en todo el mundo. Opera a través de tres segmentos: Nutrición y Salud Humana, Nutrición y Salud Animal, y Productos Especiales. El segmento de Nutrición Humana y Salud suministra ingredientes a la industria alimentaria y de bebidas.
Resumen de fundamentos de Balchem Corporation
| Estadísticas fundamentales de BCPC | |
|---|---|
| Capitalización bursátil | US$4.56b |
| Beneficios(TTM) | US$108.54m |
| Ingresos (TTM) | US$922.44m |
42.0x
Ratio precio-beneficio (PE)4.9x
Ratio precio-ventas (PS)¿Está BCPC sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de BCPC | |
|---|---|
| Ingresos | US$922.44m |
| Coste de los ingresos | US$620.38m |
| Beneficio bruto | US$302.06m |
| Otros gastos | US$193.51m |
| Beneficios | US$108.54m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 03, 2024
| Beneficios por acción (BPA) | 3.36 |
| Margen bruto | 32.75% |
| Margen de beneficio neto | 11.77% |
| Ratio deuda/patrimonio | 29.4% |
¿Cómo se ha desempeñado BCPC a largo plazo?
Ver rendimiento histórico y comparativa